Aemetis (NASDAQ:AMTX) Upgraded by Wall Street Zen to “Hold” Rating

Posted by Brenda Bartman on May 18th, 2026

Wall Street Zen upgraded shares of Aemetis (NASDAQ:AMTX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Sunday.

Other analysts also recently issued research reports about the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research note on Monday, April 20th. Ascendiant Capital Markets boosted their price target on Aemetis from $20.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, April 8th. Finally, Loop Capital set a $1.75 price target on Aemetis in a research note on Thursday, March 12th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $8.58.

Read Our Latest Stock Analysis on AMTX

Aemetis Price Performance

Shares of AMTX stock opened at $2.29 on Friday. The stock’s fifty day moving average price is $2.60 and its 200 day moving average price is $1.96. The company has a market cap of $161.15 million, a price-to-earnings ratio of -1.92 and a beta of 1.46. Aemetis has a 1-year low of $1.30 and a 1-year high of $3.80.

Aemetis (NASDAQ:AMTX – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.06). The business had revenue of $54.62 million during the quarter, compared to analyst estimates of $66.70 million. As a group, equities research analysts anticipate that Aemetis will post -0.86 earnings per share for the current year.

Institutional Trading of Aemetis

A number of hedge funds have recently modified their holdings of AMTX. Goldman Sachs Group Inc. boosted its stake in shares of Aemetis by 71.9% in the first quarter. Goldman Sachs Group Inc. now owns 218,404 shares of the specialty chemicals company’s stock worth $380,000 after buying an additional 91,367 shares during the last quarter. Creative Planning purchased a new stake in shares of Aemetis in the second quarter worth about $30,000. Russell Investments Group Ltd. boosted its stake in shares of Aemetis by 412.9% in the second quarter. Russell Investments Group Ltd. now owns 80,754 shares of the specialty chemicals company’s stock worth $200,000 after buying an additional 65,010 shares during the last quarter. Jump Financial LLC purchased a new stake in shares of Aemetis in the second quarter worth about $64,000. Finally, Qube Research & Technologies Ltd purchased a new stake in shares of Aemetis in the second quarter worth about $246,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

(Get Free Report)

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.